Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saara Metso

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
European Journal of Clinical Pharmacology|November 8, 2003
The effect of long-term microcrystalline chitosan therapy on plasma lipids and glucose concentrations in subjects with increased plasma total cholesterol: a randomised placebo-controlled double-blind crossover trial in healthy men and womenSaara Metso, Ritva Ylitalo, Matti Nikkilä, et al.
Frontiers in Cardiovascular Medicine|August 12, 2024
Genetic testing for familial hypercholesterolemia in a Finnish cohort of patients with premature coronary artery disease and elevated LDL-C levelsAntti Jokiniitty, Markku Eskola, Saara Metso, et al.
Duodecim; Laaketieteellinen Aikakauskirja|November 10, 2015
[Insulinomas in Tampere University Hospital Special Responsibility Area in 1980-2010]Elina Uitto, Päivi Hannula, Saara Metso, et al.
Clinical Endocrinology|November 4, 2004
Long-term follow-up study of radioiodine treatment of hyperthyroidismSaara Metso, Pia Jaatinen, Heini Huhtala, et al.
Journal of Diabetes and Its Complications|March 19, 2026
Potential years of life lost and factors associated with different causes of death in type 1 diabetes in FinlandElena Keisala, Tuuli Kauppala, Sini Vanhamäki, et al.
Clinical Chemistry and Laboratory Medicine|May 19, 2005
Antibody titer against malondialdehyde-modified LDL compares with HDL cholesterol concentration in identifying angiographically verified coronary artery disease. Comparison of tests by ROC analysisRiikka Rontu, Saara Metso, Olli Jaakkola, et al.
Journal of Biomedical Science|April 25, 2003
Oxidized LDL autoantibodies are related to apolipoprotein E phenotype, independently of postprandial change in plasma triglycerides and LDL size, among patients with angiographically verified coronary artery disease and healthy controlsSaara Metso, Matti Nikkilä, Pekka Laippala, et al.
Health Economics Review|January 22, 2026
Productivity costs of type 2 diabetes with or without co-occurring substance use disorder and depressionOlli Kurkela, Saara Metso, Leena Forma, et al.
Thyroid : Official Journal of the American Thyroid Association|June 9, 2018
Cardiovascular Morbidity and Mortality After Treatment of Hyperthyroidism with Either Radioactive Iodine or ThyroidectomyEssi Ryödi, Saara Metso, Heini Huhtala, et al.
The Journal of Clinical Endocrinology and Metabolism|March 22, 2007
Increased cardiovascular and cancer mortality after radioiodine treatment for hyperthyroidismSaara Metso, Pia Jaatinen, Heini Huhtala, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
European Journal of Clinical Pharmacology|November 8, 2003
The effect of long-term microcrystalline chitosan therapy on plasma lipids and glucose concentrations in subjects with increased plasma total cholesterol: a randomised placebo-controlled double-blind crossover trial in healthy men and womenSaara Metso, Ritva Ylitalo, Matti Nikkilä, et al.
Frontiers in Cardiovascular Medicine|August 12, 2024
Genetic testing for familial hypercholesterolemia in a Finnish cohort of patients with premature coronary artery disease and elevated LDL-C levelsAntti Jokiniitty, Markku Eskola, Saara Metso, et al.
Duodecim; Laaketieteellinen Aikakauskirja|November 10, 2015
[Insulinomas in Tampere University Hospital Special Responsibility Area in 1980-2010]Elina Uitto, Päivi Hannula, Saara Metso, et al.
Clinical Endocrinology|November 4, 2004
Long-term follow-up study of radioiodine treatment of hyperthyroidismSaara Metso, Pia Jaatinen, Heini Huhtala, et al.
Journal of Diabetes and Its Complications|March 19, 2026
Potential years of life lost and factors associated with different causes of death in type 1 diabetes in FinlandElena Keisala, Tuuli Kauppala, Sini Vanhamäki, et al.
Clinical Chemistry and Laboratory Medicine|May 19, 2005
Antibody titer against malondialdehyde-modified LDL compares with HDL cholesterol concentration in identifying angiographically verified coronary artery disease. Comparison of tests by ROC analysisRiikka Rontu, Saara Metso, Olli Jaakkola, et al.
Journal of Biomedical Science|April 25, 2003
Oxidized LDL autoantibodies are related to apolipoprotein E phenotype, independently of postprandial change in plasma triglycerides and LDL size, among patients with angiographically verified coronary artery disease and healthy controlsSaara Metso, Matti Nikkilä, Pekka Laippala, et al.
Health Economics Review|January 22, 2026
Productivity costs of type 2 diabetes with or without co-occurring substance use disorder and depressionOlli Kurkela, Saara Metso, Leena Forma, et al.
Thyroid : Official Journal of the American Thyroid Association|June 9, 2018
Cardiovascular Morbidity and Mortality After Treatment of Hyperthyroidism with Either Radioactive Iodine or ThyroidectomyEssi Ryödi, Saara Metso, Heini Huhtala, et al.
The Journal of Clinical Endocrinology and Metabolism|March 22, 2007
Increased cardiovascular and cancer mortality after radioiodine treatment for hyperthyroidismSaara Metso, Pia Jaatinen, Heini Huhtala, et al.
Pageof 6